Gandhi Zainab, Mansuri Zeeshan, Bansod Snehal
Department of Infectious Diseases, University of California, San Francisco, CA USA.
Department of Psychiatry, Texas Tech University Health Science Center at Odessa/Permian Basin, Odessa, TX USA.
SN Compr Clin Med. 2020;2(10):1707-1708. doi: 10.1007/s42399-020-00462-2. Epub 2020 Aug 21.
In this letter, we discuss the potential interactions of remdesivir, the newly approved Covid-19 drug with pulmonary medications. These interactions have been summarized keeping the busy clinician in mind. While remdesivir has proven to be a safe medication generally, we here have enlisted the potential interactions of remdesivir that a clinician needs to be mindful of while prescribing the medication.
在这封信中，我们讨论了新获批的治疗新冠病毒病药物瑞德西韦与肺部用药之间可能存在的相互作用。总结这些相互作用时，我们考虑到了忙碌的临床医生的需求。虽然瑞德西韦总体上已被证明是一种安全的药物，但我们在此列出了临床医生在开具该药物处方时需要留意的瑞德西韦的潜在相互作用。
